BioXcel Therapeutics BTAI
NASDAQ BTAI
$0.80 -0.03 (-3.61%)
At close: Aug 20, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAI) Inventory (2022 - 2026)

BioXcel Therapeutics (BTAI) posted quarterly Inventory of $500000.0 for Q1 2026, down 22.12% year-over-year from $642000.0 in Q1 2025, and down 30.75% quarter-over-quarter from $722000.0 in Q4 2025.

BioXcel Therapeutics (BTAI) Inventory (2022 - 2026) Analysis & Trends

BioXcel Therapeutics' Inventory history runs 5 years deep, the most recent figure standing at $500000.0 for Q1 2026.

  • In Q1 2026, Inventory fell 22.12% year-over-year to $500000.0; the TTM figure through Mar 2026 stood at $500000.0 (down 22.12% YoY), while the FY2025 annual figure was $722000.0, up 6.33% from the prior year.
  • Inventory for Q1 2026 stood at $500000.0, down from $722000.0 in the prior quarter.
  • The five-year high for Inventory was $2.7 million in Q2 2024, with the low at $459000.0 in Q3 2025.
  • The 5-year median for Inventory is $1.4 million (2022), against an average of $1.4 million.
  • The sharpest annual moves came in 2023 and 2025: Inventory soared 186.22% in 2023, then tumbled 81.12% in 2025.
  • BioXcel Therapeutics' Inventory stood at $2.0 million in 2022, then gained by 0.3% to $2.0 million in 2023, then tumbled by 65.9% to $679000.0 in 2024, then increased by 6.33% to $722000.0 in 2025, then slumped by 30.75% to $500000.0 in 2026.
  • Business Quant data shows BTAI's Inventory at $500000.0 in Q1 2026, $722000.0 in Q4 2025, and $459000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 1.44 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 3.22 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 2.57 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 9.08 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 193.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 3.93 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 104.20 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 1.77 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 816.00 Mn
10 BioXcel Therapeutics 24.25 Mn 24.25 Mn 160,000.00 483,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 483,000.00
Mar 31, 2026 500,000.00
Dec 31, 2025 722,000.00
Sep 30, 2025 459,000.00
Jun 30, 2025 506,000.00
Mar 31, 2025 642,000.00
Dec 31, 2024 679,000.00
Sep 30, 2024 1.53 Mn
Jun 30, 2024 2.68 Mn
Mar 31, 2024 2.44 Mn
Dec 31, 2023 1.99 Mn
Sep 30, 2023 2.02 Mn
Jun 30, 2023 1.93 Mn
Mar 31, 2023 1.95 Mn
Dec 31, 2022 1.99 Mn
Sep 30, 2022 1.41 Mn
Jun 30, 2022 1.40 Mn
Mar 31, 2022 682,000.00